Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients
Sandro C. Furiati, Jonatas da Silva Catarino, Marcos Silva, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Skin Barrier Dysregulation in Psoriasis
Andreas Orsmond, Lara Bereza-Malcolm, Tom Lynch, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10841-10841
Open Access | Times Cited: 132
Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis
Dennis Freuer, Jakob Linseisen, Christa Meisinger
JAMA Dermatology (2022) Vol. 158, Iss. 11, pp. 1262-1262
Open Access | Times Cited: 86
Gut Microbiota in Psoriasis
Mihaela Cristina Buhaș, Laura Ioana Gavrilaș, Rareș Candrea, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2970-2970
Open Access | Times Cited: 76
Ameliorated Skin Inflammation through the Synergistic Effect of Gold Nanorod–Dexamethasone and Photothermal Therapy
Nam-Kyung Kim, Yong‐Gyu Jeong, Soyoung Lee, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 10, pp. 12217-12231
Closed Access | Times Cited: 9
Interleukin-17 cytokines: Effectors and targets in psoriasis—A breakthrough in understanding and treatment
Immo Prinz, Inga Sandrock, Ulrich Mrowietz
The Journal of Experimental Medicine (2019) Vol. 217, Iss. 1
Open Access | Times Cited: 74
Fermentation characteristics of novel Coriolus versicolor and Lentinus edodes kombucha beverages and immunomodulatory potential of their polysaccharide extracts
Aleksandra Sknepnek, Sergej Tomić, Dunja Miletić, et al.
Food Chemistry (2020) Vol. 342, pp. 128344-128344
Open Access | Times Cited: 53
Lactobacillus rhamnosus HDB1258 modulates gut microbiota-mediated immune response in mice with or without lipopolysaccharide-induced systemic inflammation
Sang‐Kap Han, Yeon-Jeong Shin, Dong-Yun Lee, et al.
BMC Microbiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Effect of DMARDs on the immunogenicity of vaccines
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 19
Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation
Vinod Gangadevi, Sowjanya Thatikonda, Venkatesh Pooladanda, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 40
Lactobacillus rhamnosus and Bifidobacterium longum alleviate colitis and cognitive impairment in mice by regulating IFN-γ to IL-10 and TNF-α to IL-10 expression ratios
Xiaoyang Ma, Yoon-Jung Shin, Hyo-Min Jang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Current therapeutic overview and future perspectives regarding the treatment of psoriasis
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113388-113388
Closed Access | Times Cited: 5
Human papillomavirus infection associated with increased risk of new-onset psoriasis: a nationwide population-based cohort study
Ming‐Li Chen, Wei-Ming Kao, Jing‐Yang Huang, et al.
International Journal of Epidemiology (2020) Vol. 49, Iss. 3, pp. 786-797
Open Access | Times Cited: 35
Eicosapentaenoic acid reduces the proportion of IL-17A–producing T cells in a 3D psoriatic skin model
Sophie Morin, Sarah Bélanger, Sergio Cortez Ghio, et al.
Journal of Lipid Research (2023) Vol. 64, Iss. 9, pp. 100428-100428
Open Access | Times Cited: 11
Cyclin-Dependent kinase 9 (CDK9) inhibitor Atuveciclib ameliorates Imiquimod-Induced Psoriasis-Like dermatitis in mice by inhibiting various inflammation factors via STAT3 signaling pathway
Fang Zhao, Yujie Wang, Haojie Zuo, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111652-111652
Closed Access | Times Cited: 4
Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis
Sheng‐Xiao Zhang, Jia Wang, Caihong Wang, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13, pp. 1759720X2110113-1759720X2110113
Open Access | Times Cited: 25
Changes in the Immune Profile and Chromatin Accessibility of Peripheral Regulatory T Cells in Psoriasis Patients Before and After Treatment With Biologics
Yuxi Zhang, Xiaoqing Xu, Xiaojing Zhang, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 4
Closed Access
Low-dose Interleukin-2 For Psoriasis Therapy Based on the Regulation of Th17/Treg Cell Balance in Peripheral Blood
Zusha Qiao, Wenpeng Zhao, Yan Liu, et al.
Inflammation (2023) Vol. 46, Iss. 6, pp. 2359-2373
Open Access | Times Cited: 9
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 76-76
Open Access | Times Cited: 3
Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF
Sara Notararigo, Manuel Martín‐Pastor, Juan E. Viñuela, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 9, pp. 1251-1264
Open Access | Times Cited: 19
Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation
Nam-Kyung Kim, Soyoung Lee, Jinjoo Kang, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106767-106767
Closed Access | Times Cited: 19
Incidence of Psoriasis in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Matched Cohort Study
Jung Min Moon, Jin Yong Lee, Seong‐Joon Koh, et al.
Dermatology (2021) Vol. 237, Iss. 3, pp. 330-337
Open Access | Times Cited: 18
A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis
Michela Starace, Aurora Alessandrini, Matilde Iorizzo, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 6, pp. 1165-1168
Open Access | Times Cited: 12
Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection
Shadi Tabbarah, Hakam Sulaiman, Frank Owusu, et al.
Cureus (2024)
Open Access | Times Cited: 2
Beta‐catenin non‐canonical pathway: A potential target for inflammatory and hyperproliferative state via expression of transglutaminase 2 in psoriatic skin keratinocyte
Gaurav Gupta, Yogendra Singh, Juhi Tiwari, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 18
Cytokine profiles in highly active antiretroviral treatment non-adherent, adherent and naive HIV-1 infected patients in Western Kenya
F. Fuertes El Musa, Nathan Shaviya, Fidelis Mambo, et al.
African Health Sciences (2021) Vol. 21, Iss. 4, pp. 1584-92
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top